Sinovac still prevents severe COVID-19, says DOH amid Indonesia infections | ABS-CBN

Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
Sinovac still prevents severe COVID-19, says DOH amid Indonesia infections
Sinovac still prevents severe COVID-19, says DOH amid Indonesia infections
Katrina Domingo,
ABS-CBN News
Published Jun 18, 2021 12:28 PM PHT
|
Updated Jun 18, 2021 02:36 PM PHT

MANILA (UPDATE) - Chinese-made Sinovac remains effective in preventing severe COVID-19 symptoms or virus-related deaths, the Department of Health said Friday, as officials sought to allay public fears of the jab's supposed inefficiency.
MANILA (UPDATE) - Chinese-made Sinovac remains effective in preventing severe COVID-19 symptoms or virus-related deaths, the Department of Health said Friday, as officials sought to allay public fears of the jab's supposed inefficiency.
"Let's get the vaccine. Let us not be doubtful. Let's give that confidence," DOH Undersecretary Maria Rosario Vergeire told reporters, as she responded to queries about Indonesia, where 350 fully vaccinated health workers still contracted the disease.
"Let's get the vaccine. Let us not be doubtful. Let's give that confidence," DOH Undersecretary Maria Rosario Vergeire told reporters, as she responded to queries about Indonesia, where 350 fully vaccinated health workers still contracted the disease.
Reuters reported that most of the workers who tested positive were asymptomatic and only a few needed hospitalization.
Reuters reported that most of the workers who tested positive were asymptomatic and only a few needed hospitalization.
While 350 vaccinated medical workers in Indonesia caught COVID-19, the number could still be insignificant, said Vergeire.
While 350 vaccinated medical workers in Indonesia caught COVID-19, the number could still be insignificant, said Vergeire.
ADVERTISEMENT
"Hindi po natin maikakaila na may breakthrough infections... pero kailangan pa din po natin ng kumpletong datos para ma-analyze ng maigi," she said.
"Hindi po natin maikakaila na may breakthrough infections... pero kailangan pa din po natin ng kumpletong datos para ma-analyze ng maigi," she said.
(We cannot deny that there are breakthrough infections... but we need to complete the data so we can analyze it well.)
(We cannot deny that there are breakthrough infections... but we need to complete the data so we can analyze it well.)
If Indonesia has 5,000 health workers, then 350 is just 7 percent, so the Sinovac jab is still 93 percent effective, she said.
If Indonesia has 5,000 health workers, then 350 is just 7 percent, so the Sinovac jab is still 93 percent effective, she said.
While the data remains incomplete, Filipinos should avoid doubting the effectiveness of the jab, the Undersecretary added.
While the data remains incomplete, Filipinos should avoid doubting the effectiveness of the jab, the Undersecretary added.
Vaccine manufacturers have yet to submit data on the effectiveness of their jabs against new COVID-19 variants, that are known to be more contagious than the original strain, Vergeire said.
Vaccine manufacturers have yet to submit data on the effectiveness of their jabs against new COVID-19 variants, that are known to be more contagious than the original strain, Vergeire said.
The Philippines has been mainly using Sinovac vaccines in its inoculation program.
The Philippines has been mainly using Sinovac vaccines in its inoculation program.
So far, the "overall percentage for adverse events" in the Philippines remain at 0.68 percent, the DOH official said.
So far, the "overall percentage for adverse events" in the Philippines remain at 0.68 percent, the DOH official said.
These individuals reported experiencing chills, fever, fatigue, nausea and pain in the injection site after being vaccinated, she said.
These individuals reported experiencing chills, fever, fatigue, nausea and pain in the injection site after being vaccinated, she said.
"Wala pa rin po tayong kaso ng adverse events which have direct causality with the vaccine," she said.
"Wala pa rin po tayong kaso ng adverse events which have direct causality with the vaccine," she said.
(We have yet to record adverse events which have direct causality with the vaccine.)
(We have yet to record adverse events which have direct causality with the vaccine.)
As of June 17, of the 14.2 million COVID-19 vaccine doses in the country, 9 million are from Sinovac.
As of June 17, of the 14.2 million COVID-19 vaccine doses in the country, 9 million are from Sinovac.
The Philippines is also using COVID-19 jabs from AstraZeneca, Gamaleya, and Pfizer.
The Philippines is also using COVID-19 jabs from AstraZeneca, Gamaleya, and Pfizer.
Read More:
COVID-19
coronavirus
DOH
Department of Health
Maria Rosario Vergeire
Indonesia health workers
infection
vaccine
Sinovac
ADVERTISEMENT
ADVERTISEMENT